Biochemical markers of bone turnover in seronegative spondylarthropathy: Relationship to disease activity

British Journal of Rheumatology

Volumn 36, Issue 1, 1997, Pages 50-53

  MacDonald, A G ^a,b   Birkinshaw, G ^a   Durham, B ^a   Bucknall, R C ^a   Fraser, W D ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute phase response; Pyridinium cross links; Seronegative spondylarthropathy; Type 1 procollagen carboxy terminal propeptide

Indexed keywords

ACUTE PHASE PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; COLLAGEN; CREATININE; PROCOLLAGEN; PYRIDINIUM DERIVATIVE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; SPONDYLOARTHROPATHY;

EID: 0030837976     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.1.50     Document Type: Article

References (22)

1. Ralston SH, Urquhart GDK, Brzeski M, Sturrock RD. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. Br Med J 1990; 300:563-5.
2. Will R, Palmer R, Bhalla AK, Ring F, Calin A. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989;ii:1483-7.
3. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53:117-21.
4. McLaren AM, Horden LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992;51:648-51.
5. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Siebel MJ. Evaluation of hydroxypyridinium crosslinks as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991;21:310-5.
6. Pyridinium crosslinks as markers of bone resorption. [Editorial]. Lancet 1992;340:278-9.
7. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-5.
8. Siebel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. J Rheumatol 1989;16:964-70.
9. Parfitt AM, Simon LS, Villaneuva AR, Krane SM. Procollagen type 1 carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987;2:427-36.
10. Eriksen EF, Charles P, Melson F, Mosekilde L, Risteli L, Ristelli J. Serum markers of type 1 collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993; 8:127-32.
11. Macrae IF, Wright V. Measurement of back movement. Ann Rheum Dis 1969;28:584-9.
12. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem 1988;169:197-203.
13. Birkinshaw G, Dutton J, Fraser WD. Measurement of free pyridinoline and deoxypyridinoline in urine by HPLC. Proc ACB Nat Meet 1994;B32:68.
14. Marhoffer W, Stracke H, Masoud I et al. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 1995;54:556-9.
15. Gough A, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
16. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
17. Reid DM, Kennedy NS, Smith MA, Tothill P, Nuki G. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J 1982;285:330-2.
18. Franck H, Keck E. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 1993;52:343-6.
19. Ekenstam EA, Ljunghal S, Hallgren R. Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effects of glucocorticoid and remission inducing drugs. Ann Rheum Dis 1986;45:484-90.
20. Pietschmann P, Machold KP, Wolosczuk W, Smolen JS. Serum osteocalcin concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:654-7.
21. Gevers G, Devos P, de Roo M, Dequecker J. Increased levels of osteocalcin (serum bone gla-protein) in rheumatoid arthritis. Br J Rheumatol 1986;25:260-2.
22. Pedersen BJ, Schlemmer A, Hassager C, Christiansen C. Changes in the carboxyl-terminal propeptide and other markers of bone formation upon five days of bed rest. Bone 1995;17:91-5.